Simulations Plus Reports Second Quarter Fiscal 2023 Financial Results
Total revenue of $15.8 million; Diluted Earnings Per Share (EPS) of $0.20; Maintains full-year revenue guidance of $59.3 – $62.0 million (+10-15%) and EPS Guidance of $0.63 – $0.67 LANCASTER, Calif.–(BUSINESS WIRE)–Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today reported financial results … [Read more…]
